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The bimodular 276 kDa nonribosomal peptide syn-
thetase AspA from Aspergillus alliaceus, heterolo-
gously expressed in Saccharomyces cerevisiae,
converts tryptophan and two molecules of the aro-
matic b-amino acid anthranilate (Ant) into a pair of
tetracyclic peptidyl alkaloids asperlicin C and D in
a ratio of 10:1. The first module of AspA activates
and processes two molecules of Ant iteratively to
generate a tethered Ant-Ant-Trp-S-enzyme interme-
diate onmodule two. Release is postulated to involve
tandem cyclizations, in which the first step is the
macrocyclization of the linear tripeptidyl-S-enzyme,
by the terminal condensation (CT) domain to
generate the regioisomeric tetracyclic asperlicin
scaffolds. Computational analysis of the transannu-
lar cyclization of the 11-membered macrocyclic in-
termediate shows that asperlicin C is the kinetically
favored product due to the high stability of a confor-
mation resembling the transition state for cyclization,
while asperlicin D is thermodynamically more stable.
INTRODUCTION
The aspergilli are prolific producers of polyketide and nonriboso-
mal peptide natural products, some of which appear to be
constitutive while others are conditional metabolites (Bok et al.,
2006; Sanchez et al., 2012). The peptidyl alkaloids represent a
prevalent class, typified by fused ring scaffolds with rigidified
frameworks and extended molecular architectures (Chang
et al., 1985; Gao et al., 2011; Karwowski et al., 1993; Liesch
et al., 1988; Takahashi et al., 1995). These are assembled effi-
ciently by short nonribosomal peptide synthetase (NRPS)
assembly lines (Finking and Marahiel, 2004; Sattely et al., 2008)
and then furthermodified by postassembly line tailoring enzymes
that can add electrophilic acyl, prenyl, and oxygen functionalities
in scaffold maturation events (Ames et al., 2010; Haynes et al.,
2011; Yin et al., 2009). We have recently examined the chemical870 Chemistry & Biology 20, 870–878, July 25, 2013 ª2013 Elsevier Llogic and enzymatic machinery for assembly of Aspergillus
signature metabolites such as fumiquinazolines from Aspergillus
fumigatus (Ames et al., 2011; Ames andWalsh, 2010), ardeemins
from Aspergillus fischeri (Haynes et al., 2013), and asperlicins
fromAspergillus alliaceus (Haynes et al., 2012), which are notable
for utilizing the nonproteinogenic b-amino acid anthranilate (Ant)
as a chain-initiating building block (Walsh et al., 2012, 2013; Fig-
ure 1A). The tricyclic scaffold of fumiquinazoline F is assembled
from Ant, L-tryptophan (L-Trp), and L-alanine (L-Ala) by trimodular
NRPS enzymatic action (Gao et al., 2012).
In analogy, two molecules of Ant and one L-Trp building block
are processed to the tetracyclic isomers asperlicin C and asper-
licin D (Haynes et al., 2012). Surprisingly, the AspA NRPS
presumed to assemble these asperlicin isomeric frameworks is
predicted to be bimodular, not trimodular, with bioinformatic
identification and subsequent genetic deletion analysis in the
producer (Haynes et al., 2012). This suggests either an unusual
iterative action in Ant activation or a possible third module
encoded elsewhere in the A. alliaceus genome acting in trans
with AspA. In this work, we have expressed the 276 kDa AspA
protein in Saccharomyces cerevisiae, purified it in soluble active
form, and shown that it is necessary and sufficient to produce
both asperlicin C and D in a constant ratio, indicating they
derive from a common intermediate. These tetracyclic product
regioisomers represent a dramatic morphing of the linear tripep-
tide backbone of Ant-Ant-Trp.
RESULTS
Expression and Purification of A. alliaceus AspA
To obtain the 276 kDa hexa-domain bimodular (A1-T1-C2-A2-
T2-CT, where A is adenylation, T is thiolation, and C is condensa-
tion domains; CT represents a terminal condensation domain at
the end of the NRPS assembly line) NRPS AspA (Figure 1A) from
A. alliaceus as a purified protein for catalytic characterization, we
utilized S. cerevisiae strain BJ5464-NpgA that has vacuolar pro-
teases deleted and contains a phosphopantetheinyl transferase
(NpgA) that primes the apo forms of NRPS carrier domains (Ma
et al., 2009). We previously found that this yeast strain will pro-
vide the TqaA trimodular NRPS in soluble, active form (Gao
et al., 2012). The DNA encoding the aspA gene was clonedtd All rights reserved
Figure 1. Heterologous Expression of AspA
in Saccharomyces cerevisiae
(A) Amino acid building blocks for assembly
of fumiquinazoline F (FQF) and asperlicins C
and D. AspA is a 276 kDa two-module NRPS
enzymes with the indicated adenylation (A), thio-
lation (T), and condensation (C) domains. The
terminal condensation domains (CT) of TqaA
and AspA act as cyclization/release catalysts
for Ant-d-Trp-L-Ala and Ant-Ant-L-Trp, respec-
tively, presented as thioesters on the pan-
tetheinyl arms of immediate upstream T
domains. Intramolecular capture of the thioester
carbonyl by the NH2 of Ant1 is the proposed
common release mechanism. The subsequent
transannular cyclizations and aromatizing de-
hydrations yield 6,6,6-tricyclic quinazolinedione
(fumiquinazoline F) or tetracyclic 6,6,7,6 asperlicin C/D regioisomeric scaffolds, affected by the presence or absence of Ant2 in the tripepitidyl-S-thiolation
domain intermediates.
(B) SDS-PAGE gel of AspA expressed and purified from S. cerevisiae BJ5464-NgpA.
See also Table S1.
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one intron of 63 base pairs (bp) was removed from fragment 1
before ligation to yield a 7,329 bp coding sequence, as
described in the Experimental Procedures. The full-length aspA
gene with a C-terminal His6 tag was then moved into the
S. cerevisiae strain for expression and affinity purification.
As shown in Figure 1B, the tagged AspA protein could be
purified to apparent homogeneity in soluble form with a yield of
9 mg/l. No proteolytic fragments were detected, suggesting
the six-domain protein is likely well folded.
Assay of the Adenylation Domains of AspA for Amino
Acid Activation
The scaffolds of the suite of known asperlicin metabolites sug-
gest that two molecules of Ant and one tryptophan are used as
building blocks (Haynes et al., 2012). The purified AspA protein
was assayed for the ability to form the aminoacyl-AMPs from
Ant and L-Trp via amino acid-dependent exchange of radioac-
tivity from 32PPi into ATP, a classical assay for reversible forma-
tion of acyl-adenylates (Linne and Marahiel, 2004). As shown in
Figure 2A, Ant supports robust exchange activity with a kcat =
1.6 s1, whereas L-Trp is also active with lower rates (kcat =
1.5 min1, Figure S1). No significant activity was detected with
other proteinogenic amino acids. Benzoate and salicylate as
Ant analogs also gave evidence of reversible formation of the
acyl-AMPs (Figure S1). Ant-L-Trp, Ant-D-Trp, and Ant-Ant dipep-
tides did not support exchange, suggesting they are not used as
free intermediates (Figure 2A).
We also successfully cloned and expressed protein fragments
spanning the two AspA modules. The A1-T1 construct was not
solubly expressed but the A1-T1-C2 tridomain (150 kDa) repre-
senting module 1 (M1) was soluble at a yield of 15 mg/l. Likewise
A2-T2-CT was not soluble, but the four-domain C2-A2-T2-CT
(176 kDa) representing module 2 (M2) version was soluble at a
yield of 10 mg/l (Figure S2). As shown in Figure 2A, these protein
constructs allowed unambiguous assignment that the A1 domain
in M1 activates Ant; and A2 in M2 activates L-Trp. This result
therefore strongly indicates the iterative use of Ant by M1 in syn-
thesis of the tripeptide. In addition, it was possible to expressChemistry & Biology 20,and purify in soluble form of the terminal CT (52 kDa, yield
4 mg/l) and the didomain T2-CT (61 kDa, yield 16 mg/l) fragment
from M2 (Figure S2), which proved useful in studies with di- and
tripeptidyl-S-N-acetylcysteamine (SNAC) surrogate substrates
noted later.
Holo-AspA Is Catalytically Competent to Generate Both
Asperlicin C and D and Another Product Isomer
Having isolated the intact AspA protein and verified its A
domains are catalytically active, we next examined if the bimod-
ular NPRS can produce the tripeptidyl alkaloids. When 10 mM
pure AspA was mixed with 1 mM Ant, 1 mM L-Trp, 3 mM ATP,
and 5 mM MgCl2 in 50 mM Tris-HCl at pH 7.5 for 16 hr and the
small molecules analyzed with high-performance liquid chroma-
tography (HPLC), Figure 3A shows major and minor peaks with
the elution times of standard asperlicin C and asperlicin D (Hay-
nes et al., 2012), respectively. Analysis of the peaks by mass
spectrometry confirmed that both product peaks had m/z =
407 [M + H]+, equal to that of both asperlicin C and D isomers
(Figure S3). There is one additional enzyme-dependent minor
product peak detectable in the HPLC traces, product 1, and it
too has the same m/z = 407 [M + H]+ mass.
Rate assays under those conditions indicate linear formation
rates for asperlicin C/D and the unknown product 1 (Figure 3B).
Given the known extinction coefficients (almost the same at
280 nm) of the asperlicin C and D synthetic standards, the
apparent turnover number for asperlicin C was calculated to
be 126.1 ± 7.6 h1 and that for asperlicin D is 12.0 ± 0.8 h1.
That product ratio of 10:1 does not change during the course
of the incubation, suggesting the minor product asperlicin D is
not forming from asperlicin C in a postreaction transformation,
but is in fact an initially formed alternative product of AspA.
Until the structure of the third isomeric product 1 is determined,
we cannot confidently assign a turnover number to it. How-
ever, assuming that this asperlicin isomer might have a
comparable A280 extinction coefficient, we would estimate
an apparent turnover number of 5.9 ± 0.3 h1, which repre-
sents 5% of the product flux that is also constant over the
incubation time frame. Hence, all three products are likely870–878, July 25, 2013 ª2013 Elsevier Ltd All rights reserved 871
Figure 2. Anthranilate and l-Tryptophan Are
Substrates of AspA
(A) ATP-[32P]PPi exchange assay of full length
AspA.
(B) Loading assay of A1-T1-C2 (M1) and C2-A2-T2-
CT (M2) with [
14C]anthranilate or [14C]tryptophan.
M1 activates Ant while M2 activates L-Trp. Assay
components are labeled in the figure. Data repre-
sent mean values ± SD.
See also Figures S1 and S2.
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11-membered macrolactam formed via macrocyclization of the
tripeptide.
Assay of Truncated Forms of AspA for Product
Formation: Activity of the Two Modules
To examine the iterative features of AspA, we dissected the AspA
NRPS into M1 and M2. Mixing of the purified M1 and M2 with
Ant, L-Trp, and ATP provided a reconstitution of asperlicin pro-
duction with asperlicin C and D in the same ratio as full-length
AspA and also the third minor product 1 (Figure S4). This
validates that the dissected modules can work in trans and the
tethered, activated anthranilyl moiety can be transferred produc-
tively to M2. It seemed likely that the second condensation
domain C2 would work twice in a catalytic cycle of AspA, first
in the canonical mode to condense T1-tethered Ant onto Trp-
S-T2 to yield Ant-L-Trp-S-T2 and concomitantly free the thiol in
T1-SH (where -S-T# designates the S-pantetheinyl thiolation
domain in module #). If that Ant-L-Trp-S-enzyme had a suffi-
ciently long lifetime, T1 could reload with another Ant; a second
round of transfer catalyzed by C2 would generate Ant-Ant-L-Trp-
S-T2. We sought to test these two predictions by synthesis of
dipeptidyl Ant-L-Trp-SNAC and tripeptidyl Ant-Ant-L-Trp-SNAC
and adding them as surrogate substrates to particular purified
fragments of AspA. The expectation was that HS-pantetheinyl-
T2 could engage in thioester exchange with the di- and tripep-
tidyl-SNACs to generate the corresponding Ant-L-Trp-S-T2 and
Ant-Ant-L-Trp-S-T2 forms, respectively, to allow an evaluation
of their catalytic competence.
To evaluate whether Ant-L-Trp-S-T2 was on pathway, the pu-
rified terminal didomain T2CT (50 mM) was used and converted to
the holo form by prior phosphopantetheinylation via the phos-
phopantetheinyltransferase Sfp and CoA-SH (Quadri et al.,
1998). In parallel, holo M1 (50 mM) was incubated with Ant and
ATP to produce the covalent Ant-S-T1 form. Then the two
proteins were combined, 400 mM synthetic Ant-L-Trp-SNAC
was added, and product formation assayed after 1 hr. As shown
in Figure 4A (trace ii), products with the diagnostic UV of asperli-
cins were detected; the anticipated pattern of asperlicin C/D
and 1 were detected with liquid chromatography/mass spec-
troscopy (LC/MS) analysis with focus on extracted ion m/z =
407 [M + H]+ (Figure S5). Nonenzymatic cyclization of Ant-L-
Trp-SNAC to the bicyclic benzodiazepinedione and hydrolysis
of the thioester to Ant-L-Trp acid compete with the enzymatic
consumption as we have reported previously (Gao et al.,
2012). In the absence of the AspA fragments, these spontaneous
products were detected (Figure 4A, trace i). Figure 4B shows the
proposed acyl exchange between SNAC and HS-pantetheinyl-872 Chemistry & Biology 20, 870–878, July 25, 2013 ª2013 Elsevier LT2 to yield the Ant-L-Trp-S-T2, which is competent to receive
the Ant moiety on T1 and proceed through the catalytic cycle.
T2CT Bidomain Converts Ant-Ant-L-Trp-SNAC
to the Suite of Asperlicin Products
These results suggest that Ant-Ant-L-Trp-S-T2 will be formed
from Ant-S-T1 and Ant-L-Trp-S-T2 during the AspA catalytic cy-
cle (Figure 4B). To evaluate that directly we prepared the corre-
sponding Ant-Ant-L-Trp-SNAC and added it to either the purified
CT domain or to the purified T2CT protein construct. As shown in
Figure 5A (trace iv), no asperlicins are generated in the absence
of AspA fragments, demonstrating the tripeptidyl thioester
(unlike the Ant-Trp-SNAC) is stable in solution and any cycliza-
tion requires the action of an enzyme, most likely the CT. How-
ever, the isolated CT domain was incompetent (trace iii) but the
T2CT (trace i) generated the characteristic trio of asperlicin prod-
ucts atm/z = 407 [M +H]+ in the presence of the tripeptide-SNAC
as assessed in an overnight incubation (Figure S6). Thus, the T2
domain appears essential in recognition/presentation of the
tripeptide by the CT domain. In a previous study of ours (Gao
et al., 2012), the same requirement held for presentation of
Ant-d-Trp-L-Ala to the CT domain of TqaA as a thioester bound
to the immediately upstream T in that fumiquinazoline F-gener-
ating trimodular NRPS. In the absence of CoA and Sfp, an assay
containing T2CT still produced 80% yield of the same product
mixture as shown in trace ii. Taken together, we propose asper-
licin formation in traces i and ii was initiated by the nonenzymatic
transfer of the Ant-Ant-L-Trp moiety from SNAC to the HS-
pantetheinyl arm of T2 (Figure 5B) through thioester interchange.
At that juncture, the downstream CT domain can catalyze the
intramolecular amide bond formation(s) that constitutes release
of the nascent cyclic product.
Proposed Cyclization Mechanisms of Asperlicin C and D
and Computation Prediction of Product Distributions
Insight into that common released precursor from AspA comes
from inspection of the differences between the isomeric asperli-
cin C and D and their molecular connectivity (Figure 6). The
mechanistic assumption, which is supported by the reconstitu-
tion studies with intact and dissected AspA, is that the linear
Ant-Ant-Trp-S-T2, tripeptidyl-S-enzyme is a late intermediate.
The terminal condensation domain CT would then act to release
the tripeptidyl chain by cyclization, analogous to that demon-
strated role by the CT domain of TqaA as it releases tricyclic
fumiquinazoline F (Gao et al., 2012). While an alternative macro-
cyclization mechanism may be considered as detailed in the
Discussion, the aniline NH2 of Ant1 will likely be the most compe-
tent nucleophile (Figure 6A). That release step (attack of N8 ontd All rights reserved
Figure 3. In Vitro Reconstitution of AspA
(A) LC/MS analysis (280 nm) shows purified AspA
generates asperlicin C/D and a third product 1 of
identical mass from Ant, L-Trp, and ATP;
(B) Catalytic turnover number and product parti-
tion ratios for 1, asperlicin C and D production.
Both asperlicin C and D standards were synthe-
sized from our previous study (Haynes et al., 2012).
Data represent mean ± SD. Also see Figures S3
and S4.
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fully analogous to the 6,10-bicyclic product (vide infra) we have
proposed in TqaA action to generate fumiquinazoline F (FQF)
(Gao et al., 2012; Figure 1). As shown in Figure 6A, the 11-
membered macrocycle I could be subject to transannular attack
with three different regiochemistries, by attack of each of the
three amide nitrogen (N1, N5, N8) on one of the three carbonyls
([C4 = O], [C7 = O], or [C11 = O]).
Attack of N1 on (C7 = O) across the ring generates a six-
membered and a seven-membered ring, converting the nascent
macrocycle I into a tetracyclic framework. Loss of water from the
initial addition product yields the major product (85% of the
final product flux) asperlicin C. Alternatively, amide N5 could
capture (C11 = O). This also builds additional six- and seven-
membered rings, generating a regioisomeric tetracyclic scaffold,
a dehydration step away from the minor product asperlicin D
(10% of the flux). A third potential route would be transannular
attack of N8 on (C4 =O). That would generate a third regiosiomer,
at the same mass of 406, but now with an angular 6,8,6,5 tetra-
cyclic scaffold. The very minor product 1 with the identical mass
could be this third isomer, but we were not able to isolate it in
sufficient quantity to prove structure.
To gain insight into the energetics of the three different modes
of cyclization, we performed quantum mechanical calculations
on the free energy changes (DDG) associated with each of the
products shown in Figure 6 (See Computational Details in the
Experimental Procedures). Interestingly, and as shown in Fig-
ure 7, asperlicin D is the most stable product among the three,
while the structure proposed for product 1 in Figures 6 and 7 is
much higher in energy. However, examination of other possible
cyclization outcomes of macrocycle I suggests that this is the
most likely option. These results suggest that not the thermody-
namic stability of the three possible adducts, but kinetic factors
determine the regiochemical outcome of the reaction. As also
shown in Figure 7, starting from the 6,11,6-macrocycle I,
different trans to cis isomerizations of the peptide bonds must
take place to reach conformations suitable for cyclization. These
are shown as macrocycles II, III, and IV in Figure 7 and are
appropriate for formation of asperlicin C, D, and 1, respectively.
The idea here is similar to Bruice’s NAC, or ‘‘near-attack confor-
mation’’ (Bruice, 2002; Bruice and Lightstone, 1999; Hur and
Bruice, 2003). Macrocycle II, the corresponding transition state
(TS2) leading to asperlicin C entails the most favorable pathway,
while the precursors to asperlicin D are much higher in energy,Chemistry & Biology 20, 870–878, July 25, 2013consistent with the observed 10:1 ratios
of asperlicin C/D (Figure 7). In view of
these results, it can be hypothesizedthat CT domain is responsible for recognizing and stabilizing
the adequate conformation of the 6,11,6-macrocycle by promot-
ing the isomerization of the N5–C4 = O peptide bond and direct-
ing the formation of asperlicin C. To what extent such nascent
products are released and cyclized nonenzymatically or are
cyclodehydrated on the way out of the active site of the CT
domain of AspA is a subject for subsequent evaluation.
We note that an alternate route of intramolecular release of
an Ant-Ant-L-Trp-S-T2 could be imagined, via formation of an
anthranilyl-diketopiperazine. This would involve amide N5 attack
(from the Ant2 residue) on the tripeptidyl thioester carbonyl (C11 =
O) as the chain release step (Figure 6B). Whether that amide
would be a kinetically competent nucleophile compared to the
Ant1 free NH2 groups seems less likely. Moreover, while that
putative diketopiperazine (DKP) could then undergo cyclization
and dehydration to asperlicin C, it has the wrong connectivity
to get to the observed asperlicin D framework, as noted in Fig-
ure 6B. Thus, the DKP release route is ruled out and formation
of the 6,11,6-tricyclic macrocycle I seems the likely mechanism
of AspA.
DISCUSSION
Our initial identification of the aspABC gene cluster(Haynes et al.,
2012) by sequencing of the A. alliaceus genome relied on gene
knockouts of aspA and aspB, the NRPS- and epoxygenase-
encoding genes respectively, and the accumulation of different
asperlicins in extracts from those mutants. We had synthesized
authentic samples of asperlicin C and asperlicin D both as stan-
dards and to evaluate their capacity to serve as substrates for
purified AspB, the indole epoxygenase (Haynes et al., 2012).
Given that pure AspB acted selectively on asperlicin C (to yield
asperlicin E) and not asperlicin D, we concluded that while asper-
licin Dwas a natural Aspergillusmetabolite (Liesch et al., 1988), it
was a dead end for subsequent processing to either asperlicin E
or asperlicin itself. The question remained how and why asperli-
cin D formed as a coproduct with asperlicin C.
In this study, we have turned to characterization of the NRPS
AspA enzyme. Bioinformatic analysis of AspA from the genome
sequence predicted it would have only two modules (A1-T1-C2-
A2-T2-CT) (Haynes et al., 2012), whereas asperlicin C and D are
comprised of three amino acid units, two molecules of Ant,
and one Trp. Thus, a question at the start of this study was
whether there was an additional, missing, monomodular NRPSª2013 Elsevier Ltd All rights reserved 873
Figure 4. The First Module of AspA Iteratively Uses Two Molecules of Ant
(A) The dipeptidyl Ant-L-Trp-SNAC (Gao et al., 2012) is a surrogate substrate for M2 of AspA: the holo form of M1 (50 mMA1-T1-C2) was preloaded with Ant (1 mM
Ant, 3mMATP) for 1 hr while in parallel the T2-CT didomainwas converted to the holo (HS-pantetheinyl) form using 20 mMSfp and 1mMCoASH. The two solutions
were mixed with addition of 400 mMAnt-L-Trp-SNAC and incubated overnight before aliquots were analyzed by LC/MS (280 nm). Trace i shows the spontaneous
products (S-benzodiazepinedione and Ant-L-Trp acid) formed from an assay without T2CT didomain; trace ii shows products formed from an assay including holo
T2CT. In addition to the spontaneously formed products, formation of asperlicin C can be detected. Trace iii shows the profile of products formed from full length
AspA starting from Ant, L-Trp and ATP.
(B) Reaction scheme: M1 loaded covalently with Ant on the pantetheinyl arm of T1 reacts with Ant-L-Trp-S-pantetheinyl-T2-CT to yield the tripeptidyl Ant-Ant-
L-Trp-S-T2-CT form of the bi-domain T2-CT protein fragment. That can be acted on by CT to yield asperlicin C, D and 1. The added Ant-L-Trp-SNAC is
proposed to undergo acyl exchange onto the HS-pantetheinyl arm of T2-CT in competition with hydrolysis to Ant-L-Trp and intramolecular cyclization to
S-benzodiazepinedione.
See also Figures S5 and S7.
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thioester could be tethered. Alternatively, it was possible that
bimodular AspA could act twice on Ant and generate a linear
tripeptidyl-S-T2 intermediate to be released by cyclizing action
of the CT domain (Gao et al., 2012).
To address whether AspA is sufficient to generate and release
both asperlicin C and asperlicin D, we constructed a C-terminal
His6-tagged version of the 276 kDa AspA for expression in the
vacuole protease-deficient S. cerevisiae strain BJ5464-NpgA.
This strain has been of use to us for cloning the comparably sized
bimodular AnaPS as well as the trimodular TqaA in aszonalenin
and tryptoquialanine pathways, respectively (Gao et al., 2012).
Soluble AspA with the pantetheinyl-SH prosthetic groups
installed posttranslationally on T1 and T2 was thereby obtained
in a yield approaching 9 mg/l, suitable for biochemical
characterization.
First, we assayed the capacity of holoAspA to activate Ant and
L-Trp by reversible formation of the aminoacyl-AMPs and vali-
dated that each A domain was active. Because both A1 and A2
are contained in the same protein, one could not determine
from such radioactive exchange assays if A1 was activating
Ant and A2 was activating Trp, or A2 activated both Ant and
Trp. To that end, the expression and separate purification of
C-terminally His6-tagged M1 (A1-T1-C2) and M2(C2-A2-T2-CT)
allowed that distinction. Inclusion of C2 in both constructs was
necessary to achieve soluble expression of A domain-containing
fragments. The A1-containing protein activated Ant and the
A2-containing module activated L-Trp as Trp-AMP but did not
act on Ant. The two-module AspA assembly line thus tethers
Ant to T1 and L-Trp to T2. The Ant-Ant and Ant-Trp dipeptides874 Chemistry & Biology 20, 870–878, July 25, 2013 ª2013 Elsevier Lwere not substrates for either A1 or A2 (Figure 2A). If A1 made
an Ant-Ant-tethered thioester before transferring to Trp-S-T2,
one might have expected detection of the cyclic Ant-Ant dimer.
No such dimer was detected from A1-T1-C2 incubations with Ant
and ATP (Figure S7). Mixing the M1 and M2 reconstituted asper-
licin C and D formation as efficiently as the intact AspA, proving
the separate modules could function in trans, and that the sec-
ond copy of the C2 domain was not a problem for reconstitution
(Figure S4). M1 acts iteratively, first to generate a canonical
Ant-Trp-S-T2 that is then elongated by a reloaded Ant-S-T1 to
provide the Ant-Ant-Trp-S-T2 as a full-length intermediate that
undergoes release by intramolecular cyclization.
Full length, purified AspA is clearly sufficient to make the tetra-
cyclic scaffold of asperlicin C from 2 molecules of Ant, 1 L-Trp. It
also generates asperlicin D, a known A. alliaceus minor meta-
bolite. In this study, a 10:1 constant ratio of asperlicin C:D is
observed by kinetic analysis because asperlicin D represents
10% of the product flux. The constant ratio indicates that
both products are formed from a common intermediate or
nascent product. From the failure of asperlicin D to be carried
forward by AspB, the epoxygenation enzyme that takes asperli-
cin C on to asperlicin E (Haynes et al., 2012), we have reasoned
that asperlicin D is a dead-end metabolite and so represents
off-pathway partitioning of a common precursor. The mixture
of asperlicin C and D (and 1) are also produced in the two-
module reconstitution experiment as well as in the incubations
with Ant-Trp-SNAC and Ant-Ant-Trp-SNAC as surrogate sub-
strates to probe the nature of later stage intermediates during
AspA catalysis. Computational analysis clearly indicated that
while asperlicin D is more stable, asperlicin C is the kineticallytd All rights reserved
Figure 5. The T2CT Didomain Fragment of
AspA Generates Asperlicin C and D from
Exogenous Ant-Ant-l-Trp-SNAC
(A) UV-vis analyses of HPLC traces (280 nm) from
the indicated incubations are shown. Reactions
contained 50mM Tris-HCl buffer, pH 7.5, in 100 ml.
Reactions represented by traces i to iv contained
100 mM Ant-Ant-L-Trp-SNAC. Fifty micromolar
T2CT, 20 mMSfp, and 2mMCoASHwere added to
reaction I; but only 50 mM T2CT was added in
reaction ii; 50 mMCT, 20 mMSfp, and 2mMCoASH
were added in reaction iii; No enzyme was added
in reaction iv. Traces (v–vii) are standards. The
suite of asperlicin C, D, and 1([M+H]+ = 407) are
found in traces i and ii but not in iii and iv.
(B) Reaction scheme featuring nonenzymatic acyl
exchange from the -SNAC to the T2 domain pan-
tetheinyl thiol arm to yield the tripeptidyl-S-T2
covalent enzyme as substrate for cyclizing release
by the downstream CT domain.
See also Figures S6 and S7.
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the formation of asperlicin C from AspA. The extent to which
CT domain influences the near attack conformation of themacro-
lactam in its active site is unclear. However, it is evident that the
formation of asperlicin D cannot be suppressed under experi-
mental conditions (both in vivo and in vitro), thereby giving
support to a mechanism of transannular cyclization in which
the outcomes are dictated by free-energy barriers.
The AspA NRPS illustrates the unusual cyclopeptide ring sizes
attainable in the asperlicin system and is distinct from the related
fumiquinazoline and ardeemin systems, where comparable
6,10-bicyclic nascent products gave rise to regioisomeric tricy-
clic quinazolinedione scaffolds (Gao et al., 2012; Figure 1). In
both cases we argue that the terminal CT domains are the chain
release catalysts by intramolecular capture of the thioester
carbonyl by the Ant1-NH2 group, yielding a 6, 10 (TqaA) or
6,11,6 (AspA) tricyclic nascent product. Subsequent closure to
the very different 6,6,6-tricyclic versus 6,6,7,6-tetracyclic scaf-
fold reflects the use of an additional Ant unit in the second posi-
tion of the tripeptide framework, uniquely in the asperlicin
assembly line. One planar b-amino acid unit (Ant) at the amino
terminus of a tripeptidyl thioester directs cyclization to the tricy-
clic quinazolinedione framework. The second Ant b-aminoacyl
building block adds another carbon and incorporates the fourth
ring into the final asperlicin scaffolds.
While we proposed that the aniline amine on the first Ant
residue is responsible for initiating the macrolactam formation,
there are alternative nucleophiles that may be considered to
initiate the cascade of reactions. As shown in Figure S8, in addi-
tion to the possibility that the aniline nitrogen serves as the
product-releasing nucleophile (mechanism 3), two alternative
mechanisms can be envisioned. In mechanism 1, the (C4 = O)
carbonyl oxygen in imide form could be sufficiently nucleophilic
to first attack the thioester to generate an oxazol-5(4H)-one
ring, followed by attack of the (C11 = O) carbonyl oxygen and
undergo ring expansion to yield a nine-membered ring, which
can then be opened to the 6,11,6-macrocylce I. Alternatively
in mechanism 2, the amide nitrogen bridging the two Ant
residues can initiate attack on the thioester to form a seven-Chemistry & Biology 20,membered ring, followed by ring expansion to the 6,11,6-
macrocycle I.
To assess the possibilities of these routes, we computed the
relative free energies of each transition state and product among
the three possible mechanisms (see Computational Details in the
Experimental Procedures). To locate and characterize transition
structures for these reactions, fully deprotonated nucleophiles
(both amides and anilines) were used despite the low acidities
of the aniline and amide groups (Figure S9) to locate neutral TS
including explicit solvation and a general base. Such reactions
require general base catalysis, and this is assumed to take place
in the enzyme active site. The inclusion of a general base and
solvent would be necessary to compute the barriers to various
reactions occurring in water or the enzyme. Our calculations
therefore only test the factors aside from deprotonation ener-
getics that are required to distort the different intermediates
along the reaction coordinate into various transition state geom-
etries. The energetics of deprotonation of different nucleophiles
by bases would be contributors to the actual free energies
of reaction. As shown in Figure S8, while formation of the oxazo-
lone product in mechanism 1 is kinetically possible (DDGz =
14 kcal/mol), it represents a thermodynamic dead-end that is
unlikely to undergo additional modifications. In fact, subsequent
ring expansion reactions toward either nine-membered or
seven-membered rings are kinetically unfeasible (DDGz >
35 kcal/mol). In mechanism 2, calculations showed that the
attack of the amidate nitrogen to form the seven-membered
ring is highly unfavorable (DDGz = 34 kcal/mol) and is therefore
unlikely to take place. In contrast, the direct attack of the aniline
in mechanism 3 is the favored pathway because the activation
barrier is low (DDGz = 13 kcal mol-1). These results are in good
agreement with the observed nonenzymatic reactivity of dipep-
tide Ant-l-Trp-SNAC, which undergoes fast cyclization exclu-
sively through the terminal aniline.
In conclusion, we have focused on the mechanism of AspA-
catalyzed formation of asperlicin C and D. In a previous study
we showed that the monooxygenase AspB will take asperlicin
C and perform an oxygenative cyclization to produce asperlicin
E, now with a fused heptacyclic framework (Haynes et al.,870–878, July 25, 2013 ª2013 Elsevier Ltd All rights reserved 875
Figure 6. Mechanistic Proposal for Genera-
tion of a Constant Ratio of Asperlicin C and
Asperlicin D fromMacrocyclizing Release of
a Linear Ant-Ant-L-Trp-S-T2 Thioester by the
CT Domain
(A) The attack of the free NH2 of the Ant1 residue
generates a transient 6,11,6-tricyclic product
macrocycle (I). Subsequent transannular attack
and dehydration can proceed with distinct re-
giochemistries of intramolecular amide capture of
carbonyl groups: N1 on C7 =O givesmajor product
asperlicin C, N5 onC11 =Ogives asperlicin D, while
N8 on C4 = O could give a third asperlicin
regioisomer, putative product 1. Whether these
steps happen in one of the active sites of AspA or
in solution have not yet been determined.
(B) Alternative mode of tripeptidyl chain release by
initial attack of the amide NH of Ant2 residue on the
thioester carbonyl would yield a diketopiperazine
as nascent product. That can go on to asperlicin C
as shown but has the wrong connectivity to
generate the observed minor product asperlicin D
and 1 and so is ruled out.
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enzyme pathway with economical strategy and catalytic
execution.
SIGNIFICANCE
Fungal peptidyl alkaloids represent a group of compounds
with diverse chemical structures and important biologic
activities. The planar nonproteinogenic amino acid, anthra-
nilate (Ant), is an important building block in many bioac-
tive fungal peptidyl alkaloids. Here, we heterologously
expressed the bimodular NRPS AspA in Saccharomyces
cerevisiae and successfully reconstituted AspA to produce
the regioisomers asperlicin C and D in vitro. Significantly,
differing from the canonical, colinear programming rule of
NRPSs, in which every module activates and appends one
amino acid to the growing peptide, we showed the first mod-
ule of AspA iteratively uses two molecules of Ant to build the
Ant-Ant-Trp tripeptide precursor. The C-terminal condensa-
tion domain (CT) was demonstrated to cyclize the linear
tripeptide and to produce a macrocycle that can undergo876 Chemistry & Biology 20, 870–878, July 25, 2013 ª2013 Elsevier Ltd All rights reserveddifferent intramolecular cyclization
fates. Experimental and computational
studies were performed to examine
the regioselectivity and energetics of
this step, which showed the kinetically
most favored product asperlicin C
dominates over the thermodynamically
more stable product asperlicin D.
EXPERIMENTAL PROCEDURES
Cloning of Intact aspA Gene
from A. alliaceus
The AspA encoding gene was assembled from
six pieces (P1–P6, each 1–1.5 kb) by using
modified yeast-based homologous recombinationmethods (Gao et al., 2012; Table S1). The only intron (493–555 base pairs [bp])
in the aspA gene was found with RT-PCR and no other introns were found
in other regions. The assembled AspA expression plasmid was recovered
from S. cerevisiae using a yeast plasmid miniprep II kit (Zymo Research)
and was verified by restriction digestion and PCR. Protein expression and
purification procedures are described in the Supplemental Experimental
Procedures.
ATP-[32P]PPi Exchange Assay for AspA
A typical reaction mixture (500 ml) contained 1.0 mM AspA, 1 mM substrate
(unless specified), 5 mM ATP, 10 mM MgCl2, 5 mM Na[
32P]pyrophosphate
(PPi) (1.8 3 106 cpm/ml), and 100 mM Tris-HCl (pH 8). Mixtures were incu-
bated at ambient temperature for regular time intervals (e.g., 5 min), and
150 ml aliquots were removed and quenched with 500 ml of a charcoal suspen-
sion (100 mM NaPPi, 350 mM HClO4, and 16 g/l charcoal). The mixtures were
vortexed and centrifuged at 13,000 rpm for 3 min. Pellets were washed twice
with 500 ml of wash solution (100 mM NaPPi and 350 mM HClO4). Each pellet
was resuspended in 500 ml wash solution and added to 10ml UltimaGold scin-
tillation fluid. Charcoal-bound radioactivity was measured using a Beckman
LS 6500 scintillation counter.
Loading of 14C-Substrate onto NRPS
A 50 ml assay mixture containing 100 mM HEPES (pH 7), 10 mMMgCl2, 2 mM
ATP, 1mM TCEP, 10 mM AspA-M1/M2, and 40 mM 14C-labeled substrate
Figure 7. Structures and Relative Energies Calculated for the Different Conformations of the Initial Macrocycle, Cyclization Transition
States, and Final Dehydrated Products Relevant to the Biosynthesis of Asperlicin C, D, and 1
The calculations were performed at the PCM(water)/B3LYP/6-31G(d) level using reduced models in which the indole ring from Trp side chain has been replaced
by a methyl group. Amide bonds subjected to isomerization from trans to cis orientation prior to cyclization are marked in blue. Relative free energies are in
kcal/mol and distances in angstroms.
See also Figures S8 and S9.
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The reaction was quenched by 600 ml 10% trichloroacetic acid with the addi-
tion of 100 ml of 1 mg/ml BSA. The mixture was vortexed and centrifuged at
13,000 rpm for 3 min. The pellet was then washed twice with 600 ml 10%
trichloroacetic acid, dissolved in 250 ml formic acid, added into 10 ml Ultima
Gold scintillation fluid, and subjected to a Beckman LS 6500 scintillation
counter.
Synthesis of Ant-Ant-L-Trp-SNAC
Tripeptide Ant-Ant-L-Trp was custom synthesized by GenScript USA (Piscat-
away, NJ). Thirty milligrams Ant-Ant-L-Trp (1.0 eq), 140 mg PyBOP (4.0 eq),
37mgK2CO3 (4.0 eq), and 145 mlN-acetylcysteamine (SNAC) (20 eq) were dis-
solved in 20ml H2O:THF (1:1). The solution was stirred at room temperature for
2 hours. The mixture was concentrated in vacuo, dissolved in acetonitrile, and
purified by prep-HPLC (Luna, C18 2503 21.2 mm, 10 mm, 100 A˚) using a chro-
matographic gradient: 20%–40% B, 5 min; 40%–80% B, 25 min; 80%–100%
B, 5 min (A: H2O; B: acetonitrile, 10 ml/min, monitor at 340 nm). The peak with
expected mass (m/z calculated for Ant-Ant-Trp-SNAC C29H29N5O4S [M+H]
+
544.2013, found 544.2023) was collected and lyophilized. The final yield is
19.6 mg (53%).
HPLC-Based Time Course Study of Product Formation by AspA
Master reactions (500 mL) contained 1 mM AspA, 3 mM ATP, 2 mMMgCl2, and
1mM amino acid substrates (Ant and l-Trp) and AspA in 50mM Tris-HCl buffer
(pH 7.5) were carried out at 25C and 100 ml aliquots at 1, 2, 3, and 4 hr time
points were quenched by adding 1 ml of ethyl acetate. The initial product
turnover rates were calculated with mean values ± SD by using the data
points within the linear range. The ethyl acetate layer was dried and redis-Chemistry & Biology 20,solved in methanol (100 ml), and 20 ml samples were subjected to LC/MS
analyses. Peak areas (at 280 nm) of the asperlicin C, aperlicin D, and 1 were
converted to concentrations and were used to calculate the initial enzymatic
rate (mM/hr).
Computational Details
Calculations were carried out with the B3LYP hybrid functional (Becke, 1993;
Lee et al., 1988) and 6-31G(d) basis set. Full geometry optimizations and tran-
sition structure (TS) searches were carried out with the Gaussian 09 package
(Gaussian, Wallingford, CT). The possibility of different conformations was
taken into account for all structures, and only the lowest energy structures
are discussed. Frequency analyses were carried out at the same level used
in the geometry optimizations, and the nature of the stationary points was
determined in each case according to the appropriate number of negative
eigenvalues of the Hessian matrix. The harmonic oscillator approximation in
the calculation of vibration frequencies was replaced by the quasiharmonic
approximation developed by Cramer and Truhlar (Ribeiro et al., 2011). Scaled
frequencies were not considered since significant errors in the calculated ther-
modynamic properties are not found at this theoretical level (Bauschlicher,
1995; Merrick et al., 2007). Where necessary, mass-weighted intrinsic reaction
coordinate (IRC) calculations were carried out by using the Gonzalez and
Schlegel scheme (Gonzalez and Schlegel, 1989, 1990) to ensure that the
TSs indeed connected the appropriate reactants and products. Bulk solvent
effects were considered implicitly by performing single-point energy calcula-
tions on the gas-phase optimized geometries, through the SMD polarizable
continuum model of Cramer and Thrular (Marenich et al., 2009) as
implemented in Gaussian 09. The internally stored parameters for water
were used to calculate solvation free energies (DGsolv).870–878, July 25, 2013 ª2013 Elsevier Ltd All rights reserved 877
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